comettherapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title VectivBio Announces Closing of Comet Therapeutics Acquisition – VectivBio
Description Skip to main navigation Skip to primary navigation Skip to main content Skip to primary sidebar Skip to footer VectivBio Transforming Lives Site - Header
Keywords N/A
Server Information
WebSite comettherapeutics faviconcomettherapeutics.com
Host IP 184.168.131.241
Location United States
Related Websites
Site Rank
More to Explore
comettherapeutics.com Valuation
US$910
Last updated: 2022-07-10 10:50:17

comettherapeutics.com has Semrush global rank of 0. comettherapeutics.com has an estimated worth of US$ 910, based on its estimated Ads revenue. comettherapeutics.com receives approximately 105 unique visitors each day. Its web server is located in United States, with IP address 184.168.131.241. According to SiteAdvisor, comettherapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$910
Daily Ads Revenue US$0
Monthly Ads Revenue US$25
Yearly Ads Revenue US$302
Daily Unique Visitors 7
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
comettherapeutics.com. A 600 IP: 184.168.131.241
comettherapeutics.com. NS 3600 NS Record: ns17.domaincontrol.com.
comettherapeutics.com. NS 3600 NS Record: ns18.domaincontrol.com.
comettherapeutics.com. MX 3600 MX Record: 0 comettherapeutics-com.mail.protection.outlook.com.
comettherapeutics.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2022-07-10 10:50:17
Skip to main navigation Skip to primary navigation Skip to main content Skip to primary sidebar Skip to footer VectivBio Transforming Lives Site - Header Menu About Us Management Team Board Members Investors Partners Our Focus Our Science Our Pipeline Our Clinical Trials Investors & Media Overview News & Media Events & Presentations Financial Information Stock Information Corporate Governance Shareholder Resources Contact Us Careers VectivBio Announces Closing of Comet Therapeutics Acquisition Sep 21, 2021 PDF Version - Proprietary CoMET platform aims to treat severe rare Inherited Metabolic Diseases - BASEL, Switzerland, Sept. 21, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the closing of its previously announced acquisition of Comet Therapeutics, Inc., a privately held company that has been developing drugs to address
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx/1.20.1
Date: Sun, 31 Oct 2021 01:17:35 GMT
Content-Type: text/html; charset=utf-8
Connection: close
Location: https://ir.vectivbio.com/news-releases/news-release-details/vectivbio-announces-closing-comet-therapeutics-acquisition

HTTP/1.1 200 OK
Content-Language: en
Content-Type: text/html; charset=UTF-8
device: desktop
ETag: "1635642481"
Expect-CT: max-age=0, report-uri="/report-expect-ct-violation"
Feature-Policy: accelerometer 'none';ambient-light-sensor 'none';autoplay 'self';camera 'none';encrypted-media 'none';fullscreen 'self';geolocation 'self';gyroscope 'none';magnetometer 'none';microphone 'none';midi 'none';payment 'none';picture-in-picture 'none';speaker 'self';sync-xhr 'self';usb 'none';vibrate 'none';vr 'none'
From-Origin: same
Last-Modified: Sun, 31 Oct 2021 01:08:01 GMT
Link: ; rel="canonical"
Link: ; rel="alternate"; hreflang="en"
Link: ; rel="revision"
Permissions-Policy: interest-cohort=()
Referrer-Policy: no-referrer-when-downgrade
X-Age: 574
X-Cache-Hits: 1
X-Content-Type-Options: nosniff
X-Drupal-Dynamic-Cache: UNCACHEABLE
X-Frame-Options: SAMEORIGIN
X-Request-ID: v-fe8a1d6e-39e6-11ec-973a-3f1a3a4a6f8a
X-UA-Compatible: IE=edge
X-XSS-Protection: 1; mode=block
X-EdgeConnect-MidMile-RTT: 2
X-EdgeConnect-Origin-MEX-Latency: 22
X-EdgeConnect-MidMile-RTT: 3
X-EdgeConnect-Origin-MEX-Latency: 22
Cache-Control: public, max-age=0, s-maxage=2700
Expires: Sun, 31 Oct 2021 01:17:36 GMT
Date: Sun, 31 Oct 2021 01:17:36 GMT
Connection: keep-alive
Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly
Strict-Transport-Security: max-age=15768000 ; preload
comettherapeutics.com Whois Information
Domain Name: COMETTHERAPEUTICS.COM
Registry Domain ID: 2328921271_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-11-09T15:30:16Z
Creation Date: 2018-11-02T19:51:24Z
Registry Expiry Date: 2021-11-02T19:51:24Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS17.DOMAINCONTROL.COM
Name Server: NS18.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-18T11:28:48Z <<<